Abstract | AIMS:
Macrophage colony-stimulating factor ( M-CSF) binds to colony-stimulating factor-1 receptor (CSF-1R) and stimulates proliferation and differentiation of monocytes, macrophages and their bone marrow progenitors. M-CSF, CSF-1R, the macrophage marker CD68, and the pan T-lymphocyte marker CD3 are increased in many human cancers. Their prognostic importance in primary prostatic carcinoma has not been fully delineated. The aim was to compare the expression of M-CSF, CSF-1R, CD68 and CD3 in metastatic and non-metastatic prostatic cancer. METHODS AND RESULTS: Digital video analysis of tumour cell areas and tumour stromal areas was performed in 59 cancer specimens: 32 patients with metastases and 27 patients without metastases. Expression of M-CSF and CSF-1R was recorded as 0 (negative immunoreactivity), 1 (weak), 2 (moderate) or 3 (strong reactivity). Macrophages (CD68) and T lymphocytes (CD3) were detected as proportions of moderately or strongly immunoreactive cells. Patients with metastatic primary cancers showed higher expression of M-CSF (P < 0.0001, P = 0.005), CSF-1R (both P < 0.0001) and CD3 (P = 0.007, P < 0.0001) in both tumour cell areas and tumour stromal areas, compared with the non-metastatic cancers. CONCLUSION: This study suggests that expression of M-CSF, CSF-1R and CD3 is a significant prognostic factor in primary prostatic cancers by predicting the development of metastases.
|
Authors | E Richardsen, R D Uglehus, J Due, C Busch, L-T R Busund |
Journal | Histopathology
(Histopathology)
Vol. 53
Issue 1
Pg. 30-8
(Jul 2008)
ISSN: 1365-2559 [Electronic] England |
PMID | 18510570
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD
- Antigens, Differentiation, Myelomonocytic
- Biomarkers, Tumor
- CD3 Complex
- CD68 antigen, human
- Macrophage Colony-Stimulating Factor
- Receptor, Macrophage Colony-Stimulating Factor
- Prostate-Specific Antigen
|
Topics |
- Adenocarcinoma
(diagnosis, metabolism, secondary)
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD
(metabolism)
- Antigens, Differentiation, Myelomonocytic
(metabolism)
- Biomarkers, Tumor
(metabolism)
- CD3 Complex
(metabolism)
- Humans
- Macrophage Colony-Stimulating Factor
(metabolism)
- Male
- Microscopy, Video
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Prostate-Specific Antigen
(blood)
- Prostatectomy
- Prostatic Neoplasms
(diagnosis, metabolism, surgery)
- Receptor, Macrophage Colony-Stimulating Factor
(metabolism)
|